Indian government approves monitoring plan for adverse events in organ and tissue transplantation products
read at raps ↗RegulatoryNeutral
The Indian government has given formal approval to a new program that will track adverse events linked to medicines and biologics used in organ and tissue transplantation.
The initiative is designed to collect safety data from transplant procedures, helping regulators identify potential risks associated with these products and improve patient outcomes.
By establishing a systematic monitoring framework, the government aims to strengthen oversight of transplantation therapies and align with international best practices for pharmacovigilance.
source
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “Asia-Pacific Roundup: Indian government approves adverse event monitoring plan for transplantation products”
read at raps ↗68 words · retrieved 2h ago
comments(0)
5-min edit window · permanent after that